An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies

1969 Cancer Facts and Figures

(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,811 · see citing works

15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

FORMAN, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858 · see citing works

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation

Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028 · see citing works

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,922 · see citing works

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659 · see citing works

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,262 · see citing works

Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082 · see citing works

15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway

Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004 · see citing works

Burger's Medicinal chemistry

Burger, A., & Wolff, M. E. (1980) · Wiley eBooks · Cited by 712 · see citing works

Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo–keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510067 · Cited by 649 · see citing works

Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649 · see citing works

15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway

Straus, D. S. (2000) · Medical Entomology and Zoology · Cited by 371 · see citing works

Ester and Amide Derivatives of the Nonsteroidal Antiinflammatory Drug, Indomethacin, as Selective Cyclooxygenase-2 Inhibitors

Kalgutkar, A. S. S., Marnett, A. B., Crews, B. C., Remmel, R. P., & Marnett, L. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000004e · Cited by 316 · see citing works

Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor γ

Reginato, M. J., Krakow, S. L., Bailey, S. T., & Lazar, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1855 · Cited by 279 · see citing works

α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ

Shiraki, T., Kamiya, N., Shiki, S., Kodama, T. S., Kakizuka, A., & Jingami, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500901200 · Cited by 218 · see citing works

Drug Insight: role of the androgen receptor in the development and progression of prostate cancer

Taplin, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0765 · Cited by 199 · see citing works

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

Clay, C. E., Namen, A. M., Atsumi, G., Willingham, M. C., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A., & Chilton, F. H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1905 · Cited by 184 · see citing works

Nonsteroidal Anti-Inflammatory Agents

Nickander, R. C., McMahon, F. G., & Ridolfo, A. S. (1979) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.19.040179.002345 · Cited by 177 · see citing works

Identification of a Principal mRNA Species for Human 3 -Hydroxysteroid Dehydrogenase Isoform (AKR1C3) That Exhibits High Prostaglandin D2 11-Ketoreductase Activity

Matsuura, K., Shiraishi, H., Hara, A., Sato, K., Deyashiki, Y., Ninomiya, M., & Sakai, S. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022211 · Cited by 172 · see citing works

Synthesis and Use of Iodinated Nonsteroidal Antiinflammatory Drug Analogs as Crystallographic Probes of the Prostaglandin H2 Synthase Cyclooxygenase Active Site,

Loll, P. J., Picot, D., Ekabo, O. A., & Garavito, R. M. (1996) · Biochemistry · doi:10.1021/bi952776w · Cited by 164 · see citing works

Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions

Qing Lan, B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh240 · Cited by 162 · see citing works

AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer

Rižner, T. L., Šmuc, T., Rupreht, R., Šinkovec, J., & Penning, T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.009 · Cited by 159 · see citing works

The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.

Desmond, J. C., Mountford, J. C., Drayson, M. T., Walker, E. A., Hewison, M., Ride, J. P., Luong, Q. T., Hayden, R. E., Vanin, E. F., & Bunce, C. M. (2003) · PubMed · Cited by 150 · see citing works

Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins

Penning, T. M., Jin, Y., Steckelbroeck, S., Rižner, T. L., & Lewis, M. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.006 · Cited by 142 · see citing works

Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action

Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 137 · see citing works

Expression and Characterization of Four Recombinant Human Dihydrodiol Dehydrogenase Isoforms: Oxidation of trans-7,8-Dihydroxy-7,8-dihydrobenzo[a]pyrene to the Activated o-Quinone Metabolite Benzo[a]pyrene-7,8-dione,

Burczynski, M. E., Harvey, R. G., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi972725u · Cited by 134 · see citing works

cDNA cloning, expression and characterization of human prostaglandin F synthase1

Suzuki-Yamamoto, T., Nishizawa, M., Fukui, M., Okuda‐Ashitaka, E., Nakajima, T., Ito, S., & Watanabe, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01551-3 · Cited by 131 · see citing works

Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma

Fung, K.-M., Samara, E. N. S., Wong, C., Metwalli, A., Krlin, R., Bane, B., Liu, C. Z., Yang, J. T., Pitha, J. V., Culkin, D. J., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01048 · Cited by 129 · see citing works

Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors

Penning, T. M., Steckelbroeck, S., Bauman, D. R., Miller, M. W., Jin, Y., Peehl, D. M., Fung, K.-M. A., & Lin, H.-K. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.009 · Cited by 125 · see citing works

Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes

Bauman, D. R., Rudnick, S. I., Szewczuk, L. M., Jin, Y., Gopishetty, S. R., & Penning, T. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006569 · Cited by 124 · see citing works

Crystal Structures of Prostaglandin D2 11-Ketoreductase (AKR1C3) in Complex with the Nonsteroidal Anti-Inflammatory Drugs Flufenamic Acid and Indomethacin

Lovering, A. L., Ride, J. P., Bunce, C. M., Desmond, J. C., Cummings, S. M., & White, S. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2847 · Cited by 122 · see citing works

Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate

Lin, H., Steckelbroeck, S., Fung, K.-M. A., Jones, A. N., & Penning, T. M. (2004) · Steroids · doi:10.1016/j.steroids.2004.09.014 · Cited by 111 · see citing works

Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells

Hara, A., Matsuura, K., Tamada, Y., Sato, K., Miyabe, Y., Deyashiki, Y., & ISHIDA, N. (1996) · Biochemical Journal · doi:10.1042/bj3130373 · Cited by 109 · see citing works

Crystal Structure of Human Type III 3α-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein Complexed with NADP+ and Ursodeoxycholate,

Jin, Y., Stayrook, S. E., Albert, R. H., Palackal, N. T., Penning, T. M., & Lewis, M. (2001) · Biochemistry · doi:10.1021/bi010919a · Cited by 99 · see citing works

Expression, Localization, and Signaling of Prostaglandin F2αReceptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways

Sales, K. J., Milne, S. A., Williams, A. R. W., Anderson, R. A., & Jabbour, H. N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031434 · Cited by 91 · see citing works

Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages

Aga, M., Watters, J. J., Pfeiffer, Z. A., et al. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00417.2003 · Cited by 90 · see citing works

Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors

Kalgutkar, A. S. S., Crews, B. C., Saleh, S., Prudhomme, D. R., & Marnett, L. J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.07.073 · Cited by 85 · see citing works

Prostaglandin F2αStimulates the Raf/MEK1/Mitogen-Activated Protein Kinase Signaling Cascade in Bovine Luteal Cells1

Chen, D.-B., Westfall, S. D., Fong, H. W., Roberson, M. S., & Davis, J. S. (1998) · Endocrinology · doi:10.1210/endo.139.9.6197 · Cited by 82 · see citing works

Kinetics of Allopregnanolone Formation Catalyzed by Human 3α-Hydroxysteroid Dehydrogenase Type III (AKR1C2)

Trauger, J. W., Jiang, A., Stearns, B. A., & LoGrasso, P. V. (2002) · Biochemistry · doi:10.1021/bi026109w · Cited by 81 · see citing works

The kinetic mechanism catalysed by homogeneous rat liver 3 α -hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs

Askonas, L. J., Ricigliano, J. W., & Penning, T. M. (1991) · Biochemical Journal · doi:10.1042/bj2780835 · Cited by 73 · see citing works

Molecular Basis of the Time-Dependent Inhibition of Cyclooxygenases by Indomethacin

Prusakiewicz, J. J., Felts, A. S., Mackenzie, B. S., & Marnett, L. J. (2004) · Biochemistry · doi:10.1021/bi048534q · Cited by 62 · see citing works

Multiple steps determine the overall rate of the reduction of 5α-dihydrotestosterone catalyzed by human type 3 3α-hydroxysteroid dehydrogenase: implications for the elimination of androgens

Jin, Y., & Penning, T. M. (2006) · Biochemistry · doi:10.1021/bi060591r · Cited by 60 · see citing works

Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2

Levy, M. A., Brandt, M. A., Sheedy, K. M., Dinh, J. T., Holt, D. A., Garrison, L. M., Bergsma, D. J., & Metcalf, B. W. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90145-7 · Cited by 57 · see citing works

Structure-based Inhibitor Design for an Enzyme That Binds Different Steroids

Qiu, W., Zhou, M., Mazumdar, M., Azzi, A., Ghanmi, D., Luu-The, V., Labrie, F., & Lin, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606784200 · Cited by 54 · see citing works

Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS

Koda, N., Tsutsui, Y., Niwa, H., Ito, S., Woodward, D. F., & Watanabe, K. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.02.009 · Cited by 54 · see citing works

Prostaglandin F2α Formation from Prostaglandin H2 by Prostaglandin F Synthase (PGFS): Crystal Structure of PGFS Containing Bimatoprost,

Komoto, J., Yamada, T., Watanabe, K., Woodward, D. F., & Takusagawa, F. (2006) · Biochemistry · doi:10.1021/bi051861t · Cited by 53 · see citing works

Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia

Roberts, R. O., Bergstralh, E. J., Farmer, S. A., Jacobson, D. J., Hebbring, S. J., Cunningham, J. M., Thibodeau, S. N., Lieber, M. M., & Jacobsen, S. J. (2005) · The Prostate · doi:10.1002/pros.20362 · Cited by 34 · see citing works

Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia

Mahadevan, D., DiMento, J., Croce, K. D., et al. (2006) · American Journal of Hematology · doi:10.1002/ajh.20690 · Cited by 30 · see citing works

Tamoxifen Resistant and Refractory Breast Cancer

Goss, P. E., & Strasser, K. (2002) · Drugs · doi:10.2165/00003495-200262060-00007 · Cited by 26 · see citing works

Enantiospecific, selective cyclooxygenase-2 inhibitors

Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00133-6 · Cited by 24 · see citing works

Development of affinity labeling agents based on nonsteroidal anti-inflammatory drugs: labeling of the nonsteroidal anti-inflammatory drug binding site of 3.alpha.-hydroxysteroid dehydrogenase

Askonas, L. J., & Penning, T. M. (1991) · Biochemistry · doi:10.1021/bi00113a010 · Cited by 10 · see citing works

Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs

Li, S., Hanna, E. Y., Breau, R., Ratanatharathorn, V., Xia, X., & Suen, J. Y. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601636 · Cited by 6 · see citing works

Non-steroidal anti-inflammatory agents

Heymann, M. A. (1985) · Elsevier eBooks · doi:10.1016/b978-0-407-02301-7.50010-0 · Cited by 4 · see citing works

The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders

Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · see citing works

Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism

Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217 · see citing works

Steroid hormone transforming aldo–keto reductases and cancer

Penning, T. M., & Byrns, M. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03700.x · Cited by 181 · see citing works

Structural and functional biology of aldo-keto reductase steroid transforming enzymes

Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164 · see citing works

AKR1C3 as a target in castrate resistant prostate cancer

Adeniji, A. O., Chen, M., & Penning, T. M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.012 · Cited by 143 · see citing works

Aldo–keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer

Byrns, M. C., Duan, L., Lee, S. H., Blair, I. A., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.009 · Cited by 116 · see citing works

AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders

Penning, T. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.07.002 · Cited by 117 · see citing works

Overexpression of aldo–keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride

Byrns, M. C., Mindnich, R., Duan, L., & Penning, T. M. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.012 · Cited by 60 · see citing works

Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)

Chen, M., Drury, J. E., & Penning, T. M. (2011) · Steroids · doi:10.1016/j.steroids.2011.01.003 · Cited by 53 · see citing works

New frontiers in androgen biosynthesis and metabolism

Penning, T. M. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283381a31 · Cited by 51 · see citing works

Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluation

Penning, T. M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.009 · Cited by 50 · see citing works

A Novel Homozygous Q334X Mutation in the <b><i>HSD3B2</i></b> Gene Causing Classic 3β-Hydroxysteroid Dehydrogenase Deficiency: An Unexpected Diagnosis after a Positive Newborn Screen for 21-Hydroxylase Deficiency

Jeandron, D. D., & Sahakitrungruang, T. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336004 · Cited by 27 · see citing works

Expression of human aldo–keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins

Beranič, N., Brožič, P., Brus, B., Sosič, I., Gobec, S., & Rižner, T. L. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.011 · Cited by 16 · see citing works

Steroids and Tissue Oxidation

Dorfman, R. I. (1952) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60851-1 · Cited by 18 · see citing works

[Steroid receptors and hormonal receptivity. New pharmacological and therapeutic approaches applicable to the control of fertility].

Baulieu, É.-É. (1976) · PubMed

Amino Acid Sequence and Characterization of Aldo-keto Reductase from Bakers’ Yeast

Nakamura, K., Kondo, S., Kawai, Y., et al. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.375 · Cited by 38 · see citing works

Steroid hormones: Interactions with membrane-bound receptors

Chen, H. C., & Farese, R. V. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80300-5 · Cited by 45 · see citing works

[Receptor mechanisms of action of sex hormones. Can the receptor work without a ligand?]

Бабичев, В. Н. (2006) · PubMed · doi:10.14341/probl200652132-38